Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice

Holly R. Davison, Stephanie Taylor, Chris Drake, Puay Wah Phuan, Nico Derichs, Chenjuan Yao, Ella F. Jones, Julie Sutcliffe, A. S. Verkman, Mark J. Kurth

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We previously reported the identification and structure-activity analysis of bithiazole-based correctors of defective cellular processing of the cystic fibrosis-causing CFTR mutant, ΔF508-CFTR. Here, we report the synthesis and uptake of a functional, fluorescently labeled bithiazole corrector. Following synthesis and functional analysis of four bithiazole-fluorophore conjugates, we found that 5, a bithazole-based BODIPY conjugate, had low micromolar potency for correction of defective ΔF508-CFTR cellular misprocessing, with comparable efficacy to benchmark corrector corr-4a. Intravenous administration of 5 to mice established its stability in extrahepatic tissues for tens of minutes. By fluorescence imaging of whole-body frozen slices, fluorescent corrector 5 was visualized strongly in gastrointestinal organs, with less in lung and liver. Our results provide proof-of-concept for mapping the biodistribution of a ΔF508-CFTR corrector by fluorophore labeling and fluorescence imaging of whole-body slices.

Original languageEnglish (US)
Pages (from-to)2593-2599
Number of pages7
JournalBioconjugate Chemistry
Volume22
Issue number12
DOIs
StatePublished - Dec 21 2011

Fingerprint

Fluorophores
Optical Imaging
Fluorescence
Imaging techniques
Benchmarking
Functional analysis
Cystic Fibrosis
Intravenous Administration
Liver
Labeling
Tissue
Lung
Processing
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Organic Chemistry
  • Pharmaceutical Science
  • Biomedical Engineering
  • Pharmacology

Cite this

Davison, H. R., Taylor, S., Drake, C., Phuan, P. W., Derichs, N., Yao, C., ... Kurth, M. J. (2011). Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice. Bioconjugate Chemistry, 22(12), 2593-2599. https://doi.org/10.1021/bc2004457

Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice. / Davison, Holly R.; Taylor, Stephanie; Drake, Chris; Phuan, Puay Wah; Derichs, Nico; Yao, Chenjuan; Jones, Ella F.; Sutcliffe, Julie; Verkman, A. S.; Kurth, Mark J.

In: Bioconjugate Chemistry, Vol. 22, No. 12, 21.12.2011, p. 2593-2599.

Research output: Contribution to journalArticle

Davison, HR, Taylor, S, Drake, C, Phuan, PW, Derichs, N, Yao, C, Jones, EF, Sutcliffe, J, Verkman, AS & Kurth, MJ 2011, 'Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice', Bioconjugate Chemistry, vol. 22, no. 12, pp. 2593-2599. https://doi.org/10.1021/bc2004457
Davison, Holly R. ; Taylor, Stephanie ; Drake, Chris ; Phuan, Puay Wah ; Derichs, Nico ; Yao, Chenjuan ; Jones, Ella F. ; Sutcliffe, Julie ; Verkman, A. S. ; Kurth, Mark J. / Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice. In: Bioconjugate Chemistry. 2011 ; Vol. 22, No. 12. pp. 2593-2599.
@article{8eb7d5a112a142daa0d6aef3815d658a,
title = "Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice",
abstract = "We previously reported the identification and structure-activity analysis of bithiazole-based correctors of defective cellular processing of the cystic fibrosis-causing CFTR mutant, ΔF508-CFTR. Here, we report the synthesis and uptake of a functional, fluorescently labeled bithiazole corrector. Following synthesis and functional analysis of four bithiazole-fluorophore conjugates, we found that 5, a bithazole-based BODIPY conjugate, had low micromolar potency for correction of defective ΔF508-CFTR cellular misprocessing, with comparable efficacy to benchmark corrector corr-4a. Intravenous administration of 5 to mice established its stability in extrahepatic tissues for tens of minutes. By fluorescence imaging of whole-body frozen slices, fluorescent corrector 5 was visualized strongly in gastrointestinal organs, with less in lung and liver. Our results provide proof-of-concept for mapping the biodistribution of a ΔF508-CFTR corrector by fluorophore labeling and fluorescence imaging of whole-body slices.",
author = "Davison, {Holly R.} and Stephanie Taylor and Chris Drake and Phuan, {Puay Wah} and Nico Derichs and Chenjuan Yao and Jones, {Ella F.} and Julie Sutcliffe and Verkman, {A. S.} and Kurth, {Mark J.}",
year = "2011",
month = "12",
day = "21",
doi = "10.1021/bc2004457",
language = "English (US)",
volume = "22",
pages = "2593--2599",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice

AU - Davison, Holly R.

AU - Taylor, Stephanie

AU - Drake, Chris

AU - Phuan, Puay Wah

AU - Derichs, Nico

AU - Yao, Chenjuan

AU - Jones, Ella F.

AU - Sutcliffe, Julie

AU - Verkman, A. S.

AU - Kurth, Mark J.

PY - 2011/12/21

Y1 - 2011/12/21

N2 - We previously reported the identification and structure-activity analysis of bithiazole-based correctors of defective cellular processing of the cystic fibrosis-causing CFTR mutant, ΔF508-CFTR. Here, we report the synthesis and uptake of a functional, fluorescently labeled bithiazole corrector. Following synthesis and functional analysis of four bithiazole-fluorophore conjugates, we found that 5, a bithazole-based BODIPY conjugate, had low micromolar potency for correction of defective ΔF508-CFTR cellular misprocessing, with comparable efficacy to benchmark corrector corr-4a. Intravenous administration of 5 to mice established its stability in extrahepatic tissues for tens of minutes. By fluorescence imaging of whole-body frozen slices, fluorescent corrector 5 was visualized strongly in gastrointestinal organs, with less in lung and liver. Our results provide proof-of-concept for mapping the biodistribution of a ΔF508-CFTR corrector by fluorophore labeling and fluorescence imaging of whole-body slices.

AB - We previously reported the identification and structure-activity analysis of bithiazole-based correctors of defective cellular processing of the cystic fibrosis-causing CFTR mutant, ΔF508-CFTR. Here, we report the synthesis and uptake of a functional, fluorescently labeled bithiazole corrector. Following synthesis and functional analysis of four bithiazole-fluorophore conjugates, we found that 5, a bithazole-based BODIPY conjugate, had low micromolar potency for correction of defective ΔF508-CFTR cellular misprocessing, with comparable efficacy to benchmark corrector corr-4a. Intravenous administration of 5 to mice established its stability in extrahepatic tissues for tens of minutes. By fluorescence imaging of whole-body frozen slices, fluorescent corrector 5 was visualized strongly in gastrointestinal organs, with less in lung and liver. Our results provide proof-of-concept for mapping the biodistribution of a ΔF508-CFTR corrector by fluorophore labeling and fluorescence imaging of whole-body slices.

UR - http://www.scopus.com/inward/record.url?scp=84555186665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555186665&partnerID=8YFLogxK

U2 - 10.1021/bc2004457

DO - 10.1021/bc2004457

M3 - Article

C2 - 22034937

AN - SCOPUS:84555186665

VL - 22

SP - 2593

EP - 2599

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 12

ER -